Abortion pill mifepristone stays available by mail for now as FDA faces 6-month review deadline
A federal judge allowed the abortion pill mifepristone to continue being distributed by mail nationwide for now, but warned the Biden-era policy could soon face major legal changes as a Food and Drug Administration (FDA) safety review of the drug unfolds.The legal challenge to the U.S.









